Pfizer said it will withdraw its sickle cell disease treatment Oxbryta from all markets worldwide, after data showed an “imbalance” of fatalities and complications common …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
A bipartisan group of House and Senate lawmakers is pressuring the Biden administration to approve Lykos Therapeutics’ midomafetamine (MDMA)-assisted treatment for post-traumatic stress disorder; an
Recent studies by Zampaloni et al. and Pahil et al. published in the journal Nature describe a novel method of inhibiting the growth of Gram-negative
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS